Product NDC: | 66302-206 |
Proprietary Name: | TYVASO |
Non Proprietary Name: | treprostinil |
Active Ingredient(s): | 1.74 mg/2.9mL & nbsp; treprostinil |
Administration Route(s): | ORAL |
Dosage Form(s): | INHALANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66302-206 |
Labeler Name: | United Therapeutics Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022387 |
Marketing Category: | NDA |
Start Marketing Date: | 20090814 |
Package NDC: | 66302-206-03 |
Package Description: | 4 AMPULE in 1 BOX (66302-206-03) > 2.9 mL in 1 AMPULE |
NDC Code | 66302-206-03 |
Proprietary Name | TYVASO |
Package Description | 4 AMPULE in 1 BOX (66302-206-03) > 2.9 mL in 1 AMPULE |
Product NDC | 66302-206 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | treprostinil |
Dosage Form Name | INHALANT |
Route Name | ORAL |
Start Marketing Date | 20090814 |
Marketing Category Name | NDA |
Labeler Name | United Therapeutics Corp. |
Substance Name | TREPROSTINIL |
Strength Number | 1.74 |
Strength Unit | mg/2.9mL |
Pharmaceutical Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |